🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This single dose study was designed in accordance with EMA (the European Me...
Status
Completed
Location
Altasciences Company Inc.
Start Date
2019-07-11
Trial ID
NCT04012307
Treatments Being Tested
The purpose of this study is to evaluate the non-inferiority clinical effic...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-11
Trial ID
NCT02521233
The purpose of this study is to see if Candesartan, once daily (QD), added ...
Status
Completed
Location
Multiple Locations
Start Date
2009-10
Trial ID
NCT01012479
Treatments Being Tested
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus res...
Status
Completed
Location
University of Utah
Start Date
2020-01-19
Trial ID
NCT04467931
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetic interaction of...
Status
Completed
Location
Research Site
Start Date
2008-10
Trial ID
NCT00905333
Treatments Being Tested
The purpose of this study is to determine the effects of candesartan, once ...
Status
Completed
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT00775840
Treatments Being Tested
The PHYSIC study aims to investigate the potential for precision medicine i...
Status
Completed
Location
Uppsala University hospital, Internal medicine research, Oscar II
Start Date
2017-02-20
Trial ID
NCT02774460
Treatments Being Tested
The purpose of this study is to determine the efficacy of candesartan, once...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00775814
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of long-te...
Status
Completed
Location
Multiple Locations
Start Date
2009-04-01
Trial ID
NCT02016183
Treatments Being Tested
This study will evaluate the safety and efficacy of a new combination of 3 ...
Status
Completed
Location
Hospital de Urgência e Emergência de Rio Branco
Start Date
2023-08-22
Trial ID
NCT05920005